← brief for 2026-08-26 · Slowing decline

Colquhounia Root Tablet as an immune-metabolic adjunct for residual kidney risk in heavy-proteinuric type 2 diabetic kidney disease: a propensity-score-matched real-world study.

Article C Peer reviewed Observational

Key takeaways

This study compared 128 people with heavy protein in their urine and type 2 kidney disease who took Colquhounia Root Tablet with a similar group who did not. Those taking the herbal medicine had slower decline in kidney filtering rate (eGFR). Because it used past medical records and matched groups, it shows a link but not proof that the tablet caused the benefit.

Who did this work

Zhu L · Wang K · Bian C · Sheng P · Yu J · An X

Source

Article · PubMed, the drug frontier · 2026 Aug 25
https://pubmed.ncbi.nlm.nih.gov/42641804/